Last reviewed · How we verify

NCT03747640

Self Transcranial Direct Current Stimulation and Mindfulness-based Meditation for Pain in Older Adults With Knee Osteoarthritis

Completed NA Results posted Last updated 25 March 2022
What this trial tests

NA trial testing Self Transcranial Direct Current Stimulation (tDCS) in Knee Osteoarthritis in 30 participants. Completed in 8 March 2019.

Timeline
28 November 2018
Primary endpoint
8 March 2019
8 March 2019

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date28 November 2018
Primary completion8 March 2019
Estimated completion8 March 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 50 to 85, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in Clinical Pain as Assessed by a Numeric Rating Scale for Pain (NRS) Primary · baseline, 2 weeks

The NRS assess average pain over the past 24 hours from 0 (no pain) to 100 (most intense pain imaginable).

GroupValue95% CI
tDCS With Mindfulness-based Meditation-24.67± 12.88
Sham tDCS With Sham Meditation-3.33± 10.63
Change in Clinical Pain as Assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Secondary · baseline, 2 weeks

The WOMAC ranges from 0 to 96, with higher scores indicating worse osteoarthritis (OA) pain-related symptoms.

GroupValue95% CI
tDCS With Mindfulness-based Meditation-12.60± 17.97
Sham tDCS With Sham Meditation-0.53± 10.01
Psychosocial Symptoms as Assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety-short Form Secondary · baseline

The 7-item PROMIS Anxiety Short Form assesses the pure domain of anxiety in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 7 to 35 with higher scores indicating greater severity of anxiety.

GroupValue95% CI
tDCS With Mindfulness-based Meditation17.13± 5.66
Sham tDCS With Sham Meditation16.20± 5.41
Psychosocial Symptoms as Assessed by the PROMIS Anxiety-short Form Secondary · 2 weeks

The 7-item PROMIS Anxiety Short Form assesses the pure domain of anxiety in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 7 to 35 with higher scores indicating greater severity of anxiety.

GroupValue95% CI
tDCS With Mindfulness-based Meditation14.27± 6.71
Sham tDCS With Sham Meditation14.27± 5.68
Psychosocial Symptoms as Assessed by PROMIS Depression-short Form Secondary · baseline

The 8-item PROMIS Depression Short Form assesses the pure domain of depression in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression.

GroupValue95% CI
tDCS With Mindfulness-based Meditation13.93± 7.74
Sham tDCS With Sham Meditation14.00± 5.39
Psychosocial Symptoms as Assessed by PROMIS Depression-short Form Secondary · 2 weeks

The 8-item PROMIS Depression Short Form assesses the pure domain of depression in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression.

GroupValue95% CI
tDCS With Mindfulness-based Meditation11.93± 6.94
Sham tDCS With Sham Meditation12.20± 4.83
Psychosocial Symptoms as Assessed by PROMIS Sleep Disturbance-short Form Secondary · baseline

The 8-item PROMIS Sleep Disturbance Short Form assesses the pure domain of sleep disturbance in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of sleep disturbance.

GroupValue95% CI
tDCS With Mindfulness-based Meditation23.87± 7.22
Sham tDCS With Sham Meditation23.67± 7.49
Psychosocial Symptoms as Assessed by PROMIS Sleep Disturbance-short Form Secondary · 2 weeks

The 8-item PROMIS Sleep Disturbance Short Form assesses the pure domain of sleep disturbance in individuals age 18 and older, and each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of sleep disturbance.

GroupValue95% CI
tDCS With Mindfulness-based Meditation18.27± 4.43
Sham tDCS With Sham Meditation21.13± 7.06
Psychosocial Symptoms as Assessed by the Pain Catastrophizing Scale (PCS) Secondary · baseline

The Pain Catastrophizing Scale (PCS) consists of 13 items assessing three components of catastrophizing: rumination, magnification, and helplessness. Each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time).The PCS total score is computed by summing responses to all 13 items, with total scores ranging from 0 - 52. Higher scores indicate a worse outcome.

GroupValue95% CI
tDCS With Mindfulness-based Meditation21.53± 14.46
Sham tDCS With Sham Meditation16.73± 13.15
Psychosocial Symptoms as Assessed by the Pain Catastrophizing Scale (PCS) Secondary · 2 weeks

The Pain Catastrophizing Scale (PCS) consists of 13 items assessing three components of catastrophizing: rumination, magnification, and helplessness. Each item rated on a 5-point scale: 0 (Not at all) to 4 (all the time).The PCS total score is computed by summing responses to all 13 items, with total scores ranging from 0 - 52. Higher scores indicate a worse outcome.

GroupValue95% CI
tDCS With Mindfulness-based Meditation15.80± 13.62
Sham tDCS With Sham Meditation14.80± 14.97
Psychosocial Symptoms as Assessed by the Freiburg Mindfulness Inventory (FMI) Secondary · baseline

The Freiburg Mindfulness Inventory (FMI) is a 14-item instrument. Respondents indicate their experiences relating to the items on a 4-point Likert scale (rarely, occasionally, fairly often and almost always), and the total score is calculated by adding all the scores on the 14 items of the FMI. Total scores range from 14-56, with higher scores indicating higher levels of mindfulness.

GroupValue95% CI
tDCS With Mindfulness-based Meditation41.13± 5.60
Sham tDCS With Sham Meditation36.40± 7.01
Psychosocial Symptoms as Assessed by the Freiburg Mindfulness Inventory (FMI) Secondary · 2 weeks

The Freiburg Mindfulness Inventory (FMI) is a 14-item instrument. Respondents indicate their experiences relating to the items on a 4-point Likert scale (rarely, occasionally, fairly often and almost always), and the total score is calculated by adding all the scores on the 14 items of the FMI. Total scores range from 14-56, with higher scores indicating higher levels of mindfulness.

GroupValue95% CI
tDCS With Mindfulness-based Meditation42.67± 6.98
Sham tDCS With Sham Meditation38.93± 7.43

Sponsor's own description

The purpose of this study is to determine the feasibility and preliminary efficacy of a two-week self tDCS and mindfulness-based meditation for pain in older adults with knee osteoarthritis (OA).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03747640.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing